✦ LIBER ✦

What Is the Economic Value of Digoxin Therapy in Congestive Heart Failure Patients? Results From the DIG Trial

✍ Scribed by Eric L. Eisenstein; Salim Yusuf; Vishal Bindal; Martial G. Bourassa; Anne Horney; Joseph F. Collins; Daniel B. Mark

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Digoxin in high risk chronic

✍ Varun S. Narain 📂 Article 📅 2012 🏛 Cardiological Society of India 🌐 English ⚖ 139 KB

Randomized study assessing the effect of

✍ Barry F. Uretsky; James B. Young; F.Eden Shahidi; Larry G. Yellen; Maria C. Harr 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 1015 KB

Multinational economic evaluation of val

✍ Shelby D Reed; Joëlle Y Friedman; Eric J Velazquez; Ari Gnanasakthy; Robert M Ca 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 159 KB

CV3: VASOPEPTIDASE INHIBITOR REDUCES IN-

✍ EL Eisenstein; CL Nelson; TA Simon; AL Smitten; P Lapuerta; DB Mark 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Management of elderly patients with cong

✍ Hans Peter Brunner–La Rocca; Peter Theo Buser; Ruth Schindler; Alain Bernheim; P 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Chronic Monitoring of Heart Failure Pati

✍ Inder S. Anand; Vijay K. Chopra; Naveen C. Reddy; Imad Libbus 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB